Preventive effect of Bushimatsu and Keishikajutsubuto on peripheral neurotoxicity of Oxaliplatin(L-OHP) therapy: a phase II clinical study.

ABSTRACT: Interventions: Administration of Keishikajutsubuto (TJ - 18) + Bushi matsu (TJ - 3023) Primary outcome(s): dose limiting toxicity, maximum tolerated dose, recommended Dose Study Design: single arm study, open(masking not used), uncontrolled control, single assignment, treatment purpose

DISEASE(S): Colorectal Cancer

PROVIDER: 2615226 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR